Trulieve Cannabis Corp (TCNNF)
6.80
+0.23
(+3.50%)
USD |
OTCM |
Nov 15, 16:00
Trulieve Cannabis Debt to Equity Ratio: 0.3662 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.3662 |
| June 30, 2024 | 0.3487 |
| March 31, 2024 | 0.347 |
| December 31, 2023 | 0.3413 |
| September 30, 2023 | 0.409 |
| June 30, 2023 | 0.441 |
| March 31, 2023 | 0.3455 |
| December 31, 2022 | 0.3357 |
| September 30, 2022 | 0.2751 |
| June 30, 2022 | 0.2602 |
| March 31, 2022 | 0.2608 |
| December 31, 2021 | 0.2234 |
| September 30, 2021 | 0.1671 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.1807 |
| March 31, 2021 | 0.0371 |
| December 31, 2020 | 0.3018 |
| September 30, 2020 | 0.3324 |
| June 30, 2020 | 0.4238 |
| March 31, 2020 | 0.4488 |
| December 31, 2019 | 0.1423 |
| September 30, 2019 | 0.3316 |
| June 30, 2019 | 0.4463 |
| March 31, 2019 | 0.1695 |
| December 31, 2018 | 0.1926 |
| September 30, 2018 | 0.2162 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0371
Minimum
Mar 2021
0.4488
Maximum
Mar 2020
0.2994
Average
0.334
Median
Debt to Equity Ratio Benchmarks
| Bruker Corp | 1.271 |
| Karyopharm Therapeutics Inc | -1.194 |
| Apellis Pharmaceuticals Inc | 1.907 |
| cbdMD Inc | 0.4551 |
| Flora Growth Corp | 0.3304 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.874B |
| Total Liabilities (Quarterly) | 1.566B |
| Shareholders Equity (Quarterly) | 1.312B |
| Current Ratio | 4.411 |
| Net Debt Paydown Yield | 1.44% |